Words for clinical notes
Search 5,131 terms by clinical wording, everyday description, or note example.
| Word | Plain-English search cue | Original note example | SOAP section | Writing task |
|---|---|---|---|---|
delayed-release | formulation designed to delay release until later in transit or time | The history refers to the delayed-release product on the original bottle. | Assessment | Medication exposure, response and adverse-effect reasoning |
dialysis clearance | removal of a substance attributable to dialysis | The dialysis clearance was documented for the modality and settings in use. | Assessment | Medication response, exposure and reconciliation |
dialyzability | extent to which a substance can be removed by dialysis | The review considers the drug's dialyzability and the treatment modality. | Assessment | Drug levels - exposure and pharmacokinetics |
digoxin | cardiac glycoside for which dose-to-draw time affects concentration interpretation | The digoxin result was collected two hours after the reported dose. | Objective | Drug levels - named analytes and exposure reports |
discontinuation symptoms | symptoms emerging after reducing or stopping a medication | Discontinuation symptoms began shortly after the last regular dose. | Assessment | Medication response, exposure and reconciliation |
distribution-phase sample | sample collected while drug is still distributing substantially between compartments | The distribution-phase sample limits comparison with a target defined at a later time. | Assessment | Medication response, exposure and reconciliation |
distribution half-life | time for the concentration contribution of the distribution phase to decrease by half | The early decline reflects the distribution half-life in the fitted two-compartment model. | Assessment | Drug concentrations, exposure and assay interpretation |
distribution phase | period during which drug moves between body compartments | The early specimen may reflect the distribution phase. | Assessment | Drug levels - exposure and pharmacokinetics |
dose-dependent effect | size or likelihood of an effect varies with the administered dose | Dose-dependent effect was suggested by symptom changes at two documented doses. | Assessment | Medication response, exposure and reconciliation |
dose-normalized AUC | area under the concentration-time curve divided by the administered dose | The team compared dose-normalized AUC using the same AUC interval in both periods. | Assessment | Drug concentrations, exposure and assay interpretation |
dose-normalized peak | peak concentration divided by the dose used for that observation | The dose-normalized peak was interpreted with the formulation and sampling window. | Assessment | Drug concentrations, exposure and assay interpretation |
dose-normalized trough | trough concentration divided by a defined dose metric | Dose-normalized trough was compared only across samples with confirmed predose timing. | Assessment | Medication response, exposure and reconciliation |
dose-response | relationship between administered dose and effect | The symptom diary suggests a dose-response pattern, although timing varies. | Assessment | Medication exposure, response and adverse-effect reasoning |
doubled | twice the usual quantity was taken | Reports having doubled one dose after misreading the label. | Subjective | Sequence, exposures and use of medicines |
driving cessation | stopping driving voluntarily or on advice | The patient reports driving cessation since the episode of impaired awareness. | Subjective | Activities, exposure and recovery history |
duplicate active order | two orders remain active for the same intended treatment | Duplicate active order was noted after the transfer between units. | Assessment | Medication response, exposure and reconciliation |
early refill pattern | repeated dispensing earlier than the expected end of supply | The early refill pattern was reviewed alongside documented changes in daily use. | Assessment | Medication response, exposure and reconciliation |
effective half-life | half-life used to describe accumulation or decline for the specified situation | The interpretation specifies how the effective half-life was estimated. | Assessment | Drug concentrations, exposure and assay interpretation |
elimination | removal of drug by metabolism and excretion | The falling concentrations are being reviewed alongside renal elimination. | Assessment | Drug levels - exposure and pharmacokinetics |
elimination-phase sample | sample collected on the declining portion used to characterize elimination | The elimination-phase sample was identified using actual administration and collection times. | Assessment | Medication response, exposure and reconciliation |
enterohepatic recycling | drug or metabolite returns to circulation after biliary excretion and intestinal reabsorption | Enterohepatic recycling was discussed when interpreting the multiphasic concentration curve. | Assessment | Medication response, exposure and reconciliation |
enzyme induction | increased enzyme expression or activity affecting drug handling | A new co-medication raises the possibility of enzyme induction. | Assessment | Medication exposure, response and adverse-effect reasoning |
enzyme inhibition | reduced enzyme activity affecting drug handling | The pharmacist identifies possible enzyme inhibition by a concurrent medication. | Assessment | Medication exposure, response and adverse-effect reasoning |
erythrocyte partitioning | distribution of drug into red blood cells | The choice of whole blood as the specimen reflects erythrocyte partitioning. | Assessment | Drug concentrations, exposure and assay interpretation |
ethanol | alcohol measured in a specified specimen and unit | The blood ethanol result is recorded in the units used by the laboratory. | Objective | Drug levels - named analytes and exposure reports |